Artificial intelligence (AI) affords a unique opportunity to quantify tumour burden fully automatically, with recent work demonstrating the feasibility of using convolutional neural network (CNN) architectures to automatically segment patient disease in PSMA PET/CT scans [16–18]. The gene discussed is FOLH1; the disease is neoplasm.